Dresden's OncoRay Center Pioneers with World's First PCCT Scanner for Cancer Treatment
Dresden's OncoRay Center has made a significant stride in cancer research and treatment, becoming the first worldwide to acquire an innovative photon-counting computed tomography (PCCT) scanner. This acquisition, funded by the Federal Ministry of Research, Technology and Space, further solidifies Dresden's role as a leading location for medical innovations and future-oriented cancer research.
The PCCT scanner, set to be installed in the coming weeks and ready for clinical use by mid-July, will significantly enhance treatment planning, particularly for proton therapy. This advanced technology allows for more precise imaging, reducing radiation dose for patients. The DirectSPR method, now made possible by the PCCT scanner, can treat moving tumors with greater accuracy.
OncoRay, the joint project behind this acquisition, is a collaboration between the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Medical Faculty of TU Dresden, and the University Hospital Carl Gustav Carus. This partnership has once again demonstrated its commitment to pushing the boundaries of cancer treatment.
The PCCT scanner's arrival in Dresden marks a significant milestone in cancer research and treatment. With its superior imaging capabilities and potential to reduce radiation dose, it promises to improve patient outcomes and solidify Dresden's status as a global leader in medical innovations.
